NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Bank Sees 5% YoY Growth in PAT, Despite Higher Provisions

Indian Bank reported a Profit After Tax (PAT) of INR 31.0 billion for the fourth quarter of FY26, representing a 5% year-over-year (YoY) growth. This figure missed the expected mark by 5%. The bank's Net Interest Income (NII) grew 11% YoY and 3% quarter-over-quarter (QoQ) to INR 71.1 billion, in line with the research firm's estimate of INR 70.5 billion.

The Net Interest Margin (NIM) contracted by 5 basis points (bp) to 3.23% QoQ. Advances grew 14.7% YoY and 4.7% QoQ, while deposits rose 12.3% YoY and 4.7% QoQ. Consequently, the Current Deposits (C/D) ratio remained relatively flat QoQ at 79.1%. The CASA (Current Account and Savings Account) ratio stood at 37.9%, a 50 basis point increase from the previous quarter.

Earnings Estimates and Outlook

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In light of the bank's performance, the research firm has fine-tuned its earnings estimate and anticipates Indian Bank to deliver a Return on Assets (RoA) and Return on Equity (RoE) of 1.3% and 17.6% in FY27E, respectively. The firm has reiterated its BUY recommendation for the bank, with a target price of INR 1,025. This target price is premised on 1.5 times the estimated Book Value (BV) for September 2027.

MetricQ4 FY26Q4 FY25QoQ % Change
PAT (INR billion)31.029.55%
NII (INR billion)71.164.011%
NIM (%)3.233.28-5 bp
Advances growth (YoY)14.7%12.5%2.2%
Deposits growth (YoY)12.3%11.1%1.2%

Investor Takeaway

Investors should consider maintaining a 'Buy' recommendation for Indian Bank with a target price of Rs 1,025.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.